Equity - Additional Information (Detail) $ / shares in Units, $ in Thousands	1 Months Ended		3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares	Aug. 31, 2021 USD ($) shares	Mar. 31, 2023 USD ($) security $ / shares shares	Mar. 31, 2022 USD ($)	Dec. 31, 2022 $ / shares shares
Common stock, shares authorized	150,000,000		150,000,000		150,000,000
Common stock, par value per share | $ / shares	$ 0.0001		$ 0.0001		$ 0.0001
Preferred stock, shares authorized	5,000,000		5,000,000		5,000,000
Preferred stock, par value per share | $ / shares	$ 0.0001		$ 0.0001		$ 0.0001
Shares issued during the period		1,795,524
Proceeds from Issuance of Common Stock | $			$ 36,000	$ 0
Net proceeds from shares issued | $		$ 12,300
Number of vote per common share | security			1
Maximum
Aggregate gross offering price | $		$ 250,000
Common Stock [Member]
Shares issued during the period			5,859,375
Share Purchase Agreement | ModernaTX, Inc
Shares issued during the period	5,859,375
Shares issue price (in dollars per share) | $ / shares	$ 6.14		$ 6.14
Proceeds from Issuance of Common Stock | $	$ 36,000